Did You Know...

LifeTrac now has a service focused on transplant adjacent therapies.

LifeTrac Continuum is a solution for high-cost claims associated with the complex treatments that members might require before, after, or in lieu of transplantation.

About LifeTrac

From its inception as a pioneer transplant network in 1988, LifeTrac has provided expertise to benefit payors and patients alike. Today, LifeTrac is a national network offering clinical support and access to hundreds of transplant programs at a select group of the world's leading transplant facilities. LifeTrac serves HMOs, TPAs, employer benefit plans, and major insurance, reinsurance and stop loss companies.

The LifeTrac Network was developed through the selection of transplant medical facilities that consistently demonstrate high case volumes, coupled with high patient survival rates. Each LifeTrac participating facility is carefully evaluated prior to network inclusion, and is re-evaluated annually to reconfirm the facility's ongoing adherence to LifeTrac participation standards.

LifeTrac announces the release of its new
Congenital Heart Disease program!

The treatment for Congenital Heart Disease (CHD) is often high risk and high cost. According to U.S. News & World Report, 26 percent of deaths – 1 out of every 4 – that occur following severe heart defect surgery could be prevented if the operations were performed at high-volume hospitals. By leveraging and expanding our provider relationships and clinical expertise, LifeTrac can now offer you a seamless solution to help you manage members with CHD.

LifeTrac’s Congenital Heart Disease Program gives you the support needed to manage these complex members and provide them access to top medical facilities and physicians at negotiated rates.